Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

Go back to Nurix Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
(NASDAQ: NRIX) Delayed: 26.13 -0.01 (0.04%)
Previous Close $26.14    52 Week High
Open $25.42    52 Week Low
Day High $26.42    P/E N/A 
Day Low $25.36    EPS
Volume 1,287,863